Androniki Bili - Faculty Biosketch

Androniki Bili, MD, MPH

Adjunct Assistant Professor of Medicine (Rheumatology)

7 5f

Department: Medicine

4 1 b

46 Contact information
49

Perelman School of Medicine
34 3400 Spruce Steet
Philadelphia, PA 19104

2c Office: 2156622454
30 Fax: 2156624500
24

4 3 3 3 2 4 b 1f

13 Education:
21 7 MD 1b (Medical Degree) c
4f Aristotelian University of Thessaloniki Medical School, 1990.
21 8 MPH 23 (Clinical Investigation) c
63 University of Rochester School of Public Health (Masters of Public Health), 2000.
c

3 3 21

1f Post-Graduate Training
24 5c Post Graduate Service, Lemnos General Hospital, Lemnos, Greece, 1992-1993.
24 5a Intern, Long Island Jewish Medical Center, New Hyde Park, NY, 1993-1994.
24 94 Resident, University of Rochester Primary Care Program in Internal Medicine, Rochester General Hospital. Rochester, NY, 1994-1996.
24 aa Fellowship, Fellowship in Rheumatology, Allergy, Clinical Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 1996-1999.
c

3 25

17 Certifications
28 4d Educational Commission for Foreign Medical Graduates, 1992.
28 39 Federation Licensing Examination, 1993.
28 3c American Board of Internal Medicine, 1996.
28 4b American Board of Internal Medicine - Rheumatology, 1999.
28 4b American Board of Internal Medicine - Rheumatology, 2009.
28 3c American Board of Internal Medicine, 2014.
28 4b American Board of Internal Medicine - Rheumatology, 2019.
c

3 8d Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

7 29

Selected Publications

22c Bili A, Dobson S, Quinones J, Phongsamart W, Oberdorfer P, Kosalaraksa P, Dagan R, Richmond P, Wilck M, Vallejos W, Nunn C, McFetridge R, Tamms G, Fu R, Lupinacci R, Musey L, Bickham K: A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION). Vaccine 2023 Notes: Accepted for publication 2022.

244 Russell K, Rupp RE, Morales-Ramirez JO, Diaz-Perez C, Andrews AP, Lee AW, Finn TS, Cox KS, Russell AF, Schaller MM, Martin JC, Hyatt DM, Gozlan-Kelner S, Bili A, Coller BG. : A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults Human Vaccines and Immunotherapeutics Feb 2022 Notes: https://doi.org/10.1080/21645515.2022.2046960.

df Aletaha D, Bingham CO, Karpouzas GA, Takeuchi T, Thorne C, Bili A, Agarwal P, Hsu B,Rao R, Brown K, Tanaka Y : Long-term safety and efficacy of sirukumab for patients with c6 rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE) RMD Open 2021 7: e001465, 2020 Notes: doi:10.1136/rmdopen-2020-001465.

79 Schanberg LE, Ramanan AV, De Benedetti F, Beukelman T, Eakin GS, Del Gaizo V, 2 53 Ringold S, Vesely R, Schrandt S, Jaki T, Bili A, Chung JB, De Bono S, Douglass W, 2 51 Enejosa JV, Kanik KS, Knobe K, Kunder R, Leite-Schnell JC, Suehiro RM, Wong RL, 2 46 Mieszkalski KL, Marrow LC, Siebenaler K, Fraulo E, Kimura Y. Toward 2 6d : Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis. Arthritis 2 5f Rheumatol 71(12): 1976-1984, Dec 2019 Notes: doi: 10.1002/art.41043.

e9 Sharma T, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J, Bili A.: Hydroxychloroquine use is Associated with Decreased Risk of Cardiovascular Events in Rheumatoid Arthritis Patients. 2 2 67 J Am Heart Assoc. 5(1): e002867, Jan 2016 Notes: doi: 10.1161/JAHA.115.002867.

b2 Schroeder LL, Tang X, Wasko MC, Bili A.: Glucocorticoid use is associated with increased HDL in rheumatoid arthritis patients. 41 Rheumatol Int. 35(6): 1059-67, Jun 2015.

ec Bili A, Tang X, Pranesh S, Bozaite R, Morris S, Antohe J, Kirchner HL. Wasko MC.: TNF-α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis patients. 6b Arthritis Care Res (Hoboken) 66(3): 355-63, Mar 2014 Notes: Oral Presentation

1ae Cote J, Harrington TH, Meadows A, Lin F, Bili A: Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors. The Rheumatologist Nov 2013 Notes: https://www.the-rheumatologist.org/article/fellows-forum-case-report-new-sarcoidosis-cases-in-patients-treated-with-tumor-necrosis-factoralpha-inhibitors/

a4 Cote J, Bili A: Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease. 6c ISRN Rheumatology 2013(589807), 2013 Notes: http://dx.doi.org/10.1155/2013/589807.

e2 Bili A, Morris SJ, Sartorius JA, Kirchner HL, Antohe JA, Dancea S, Wasko MCM: TNF-α inhibitor use is not associated with lipid changes in patients with rheumatoid arthritis. 3f J Rheumatol 39(5): 946-948, 2012.

2c

7 1d

2c back to top
26 Last updated: 09/20/2025
34 The Trustees of the University of Pennsylvania c